Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
The adeno-associated viruses (AAVs) can package and deliver foreign DNA into cells for corrective gene delivery applications. The AAV serotypes have distinct cell binding, transduction, and antigenic characteristics that have been shown to be dictated by the capsid viral protein (VP) sequence. To understand the contribution of capsid structure to these properties, we have determined the crystal structure of AAV serotype 4 (AAV4), one of the most diverse serotypes with respect to capsid protein sequence and antigenic reactivity. Structural comparison of AAV4 to AAV2 shows conservation of the core β strands (βB to βI) and helical (αA) secondary structure elements, which also exist in all other known parvovirus structures. However, surface loop variations (I to IX), some containing compensating structural insertions and deletions in adjacent regions, result in local topological differences on the capsid surface. These include AAV4 having a deeper twofold depression, wider and rounder protrusions surrounding the threefold axes, and a different topology at the top of the fivefold channel from that of AAV2. Also, the previously observed “valleys” between the threefold protrusions, containing AAV2's heparin binding residues, are narrower in AAV4. The observed differences in loop topologies at subunit interfaces are consistent with the inability of AAV2 and AAV4 VPs to combine for mosaic capsid formation in efforts to engineer novel tropisms. Significantly, all of the surface loop variations are associated with amino acids reported to affect receptor recognition, transduction, and anticapsid antibody reactivity for AAV2. This observation suggests that these capsid regions may also play similar roles in the other AAV serotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The AAV capsids have nine variable regions surrounded by conserved regions where the variable regions form loops and clusters on the exterior of the capsid.18–19”
From Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism (2016) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These protrusions are formed from interdigitating loops from two VPs and have the most extensive VP–VP interactions [23,24].”
From Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses (2017) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“This region has the least number of VP–VP interface interactions and represents the thinnest region of the virus capsid shell [23,24].”
From Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses (2017) · cites this paper as [23]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This includes the recombinant AAV vector rAAV2.7m8 (Dalkara et al., 2013), which is derived from the natural serotype AAV2 and was isolated by directed evolution when screening for increased transduction of the mouse retina following intravitreal (IVT) administration.”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Govindasamy et al., 2006
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828 · cited 4×
“This figure was generated using the Chimera program (54).”
MethodInfluentialThe PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320 · cited 1×
“The secondary structure elements were assigned using the DSSP program (30).”
MethodJones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 2×
“space electron density averaging, and rebuilding (6, 29).”
BackgroundMethodThe interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850 · cited 1×
“This algorithm utilizes the method of buried surface calculation reported by Lee and Richards ( 42 ), assuming a probe radius of 1.4 A.”
MethodInfluentialAQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502 · cited 1×
“angles using the PROCHECK program (41) (Table 1).”
MethodNicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240 · cited 5×
“Panels A and B were generated using the BOBSCRIPT program (15) and rendered with the RASTER3d program (48); panels C and D were generated using the GRASP program (51).”
MethodInfluentialFree R value: a novel statistical quantity for assessing the accuracy of crystal structures
Brünger, A. T. (1992) · Nature · doi:10.1038/355472a0 · Cited by 3,873 · cited 1×
“A test data set of 5% was partitioned for monitoring of the refinement process ( 5 ).”
MethodKrissinel, E., & Henrick, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904026460 · Cited by 3,760
Raster3D Version 2.0. A program for photorealistic molecular graphics
Merritt, E. A., & Murphy, M. E. P. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994006396 · Cited by 2,504 · cited 4×
“This figure was generated using the BOBSCRIPT program (15) and rendered with the RASTER3d program (48).”
MethodInfluentialAn extensively modified version of MolScript that includes greatly enhanced coloring capabilities
Esnouf, R. M. (1997) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(97)00021-1 · Cited by 1,706 · cited 7×
“Panels A and B were generated using the BOBSCRIPT program (15) and rendered with the RASTER3d program (48); panels C and D were generated using the GRASP program (51).”
MethodInfluentialNovel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520 · cited 1×
“... numerous studies, including those that use “pseudotyped” capsids, in which AAV vectors are generated using the AAV2 inverted terminal repeats to package a reporter gene (such as green fluorescent protein or luciferase) or a therapeutic gene within the capsids of other serotypes, have shown that other serotypes pos…”
BackgroundSummerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406 · cited 1×
“tical, utilize heparin sulfate as their primary receptor (59), but * Corresponding author.”
BackgroundClades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070 · cited 1×
““Pseudotyping” and “cross packaging” strategies (25, 27, 55, 56) that have enabled direct comparison of the capsids of representative serotypes of the distinct AAV clades, as well as mutagenesis studies on AAV2, the best-studied serotype, have shown that the capsid sequence determines tissue tropism, transduction effi…”
BackgroundLuscombe, N. M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.13.2860 · Cited by 981 · cited 1×
“Interestingly, the amino acids that form the nucleotide binding pocket are highly conserved between all AAVs (53), and there are other reports of amino acid-base interactions involving proline residues and adenine (46).”
BackgroundRabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762 · cited 13×
“Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4 Lakshmanan Govindasamy,1 Eric Padron,1 Robert McKenna,1 Nicholas Muzyczka,2 Nikola Kaludov,3 John A. Chiorini,3 and Mavis Agbandje-McKenna1* Department of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brai…”
BackgroundResultInfluentialBurger, C., Gorbatyuk, O. S., Velardo, M. J., Peden, C. S., Williams, P., Zolotukhin, S., Reier, P. J., Mandel, R. J., & Muzyczka, N. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.024 · Cited by 741 · cited 1×
“However, numerous studies, including those that use “pseudotyped” capsids, in which AAV vectors are generated using the AAV2 inverted terminal repeats to package a reporter gene (such as green fluorescent protein or luciferase) or a therapeutic gene within the capsids of other serotypes, have shown that other serotype…”
BackgroundSelf-citationThe atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612 · cited 8×
“A superimposition of the AAV2 VP3 model (70) onto the AAV4 electron density map identified main- and side-chain regions that were structurally different between the two serotypes (Fig.”
BackgroundMethodInfluentialDavidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531 · cited 1×
“tems of mice (13, 43) and for retinal pigmented epithelium in”
Self-citationHerzog, R. W., Hagstrom, J. N., Kung, S.-H., Tai, S. J., Wilson, J. M., Fisher, K. J., & High, K. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5804 · Cited by 474
Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., & Chiorini, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6884-6893.2001 · Cited by 427 · cited 1×
“AAV4 binds to 2,3 O-linked sialic acids, while AAV5 requires 2-3 Nlinked sialic acids for cell attachment and entry (31, 63, 64).”
BackgroundSelf-citationEfficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
Flannery, J. G., Zolotukhin, S., Vaquero, M. I., LaVail, M. M., Muzyczka, N., & Hauswirth, W. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6916 · Cited by 407
Self-citationWu, P., Xiao, W., Conlon, T., Hughes, J., Agbandje-McKenna, M., Ferkol, T., Flotte, T., & Muzyczka, N. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8635-8647.2000 · Cited by 390 · cited 2×
“In addition, alanine scanning mutagenesis of charged residues in the AAV2 VPs has shown that mutations of two-, three-, and fivefoldinterface amino acid residues can result in no-capsid phenotypes (69).”
BackgroundResultSelf-citationIdentification of a heparin-binding motif on adeno-associated virus type 2 capsids
Kern, A., Schmidt, K., Leder, C., Müller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., & Kleinschmidt, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11072-11081.2003 · Cited by 380 · cited 4×
“(C and D) Close-up views of the distributions of basic and acidic residues in the AAV2 capsid region (boxed in panel A) mapped as the heparin binding site by mutagenesis (35, 52) and the structurally equivalent region in AAV4 (boxed in panel B), respectively.”
BackgroundInfluentialChao, H., Liu, Y., Rabinowitz, J., Li, C., Samulski, R. J., & Walsh, C. E. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0219 · Cited by 366
Opie, S. R., Warrington, Agbandje-McKenna, M., Zolotukhin, S., & Muzyczka, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6995-7006.2003 · Cited by 364 · cited 4×
“(C and D) Close-up views of the distributions of basic and acidic residues in the AAV2 capsid region (boxed in panel A) mapped as the heparin binding site by mutagenesis (35, 52) and the structurally equivalent region in AAV4 (boxed in panel B), respectively.”
BackgroundMethodInfluentialSelf-citationBinding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer
Walters, R. W., Yi, S. M. P., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., & Zabner, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101559200 · Cited by 363 · cited 1×
“AAV4 binds to 2,3 O-linked sialic acids, while AAV5 requires 2-3 Nlinked sialic acids for cell attachment and entry (31, 63, 64).”
BackgroundSelf-citationThomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358
Cloning and Characterization of Adeno-Associated Virus Type 5
Chiorini, J. A., Kim, F., Yang, L., & Kotin, R. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1309-1319.1999 · Cited by 332 · cited 1×
“It has also been shown that AAV4 and AAV5, which are 55% identical to AAV2 and to each other, bind sialic acid, not heparin sulfate (11, 56).”
BackgroundSelf-citationHalbert, C. L., Allen, J. M., & Miller, A. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6615-6624.2001 · Cited by 314 · cited 1×
“Interestingly, AAV6, which is 99% identical to AAV1 and does not have residues equivalent to R585 and R588, binds heparin, but this interaction does not appear to be necessary for virus entry (23).”
BackgroundWobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9281-9293.2000 · Cited by 273 · cited 10×
“The AAV4 capsid has a unique phenotype among the AAVs in that it is not recognized by the B1 antibody, which is directed to a linear epitope (residues 726 to 733) at the conserved C-terminal end of the AAV VP3 protein (67).”
BackgroundInfluentialMori, S., Wang, L., Takeuchi, T., & Kanda, T. (2004) · Virology · doi:10.1016/j.virol.2004.10.012 · Cited by 245
Functional implications of the structure of the murine parvovirus, minute virus of mice
Agbandje-McKenna, M., Llamas-Saiz, A. L., Wang, F., Tattersall, P., & Rossmann, M. G. (1998) · Structure · doi:10.1016/s0969-2126(98)00137-3 · Cited by 218 · cited 4×
“Interestingly, CPV and MVM also have similar distributions of acidic/basic residues on the walls of their twofold axes extending toward the threefold axis (data not shown).”
BackgroundInfluentialSelf-citationSnyder, R. O., Spratt, S. K., Lagarde, C., Bohl, D., Kaspar, B., Sloan, B., Cohen, L. K., & Danos, O. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.16-1891 · Cited by 211
Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene Transfer
Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6199-6203.2001 · Cited by 207 · cited 1×
““Pseudotyping” and “cross packaging” strategies (25, 27, 55, 56) that have enabled direct comparison of the capsids of representative serotypes of the distinct AAV clades, as well as mutagenesis studies on AAV2, the best-studied serotype, have shown that the capsid sequence determines tissue tropism, transduction effi…”
BackgroundThe structure of human parvovirus B19
Kaufmann, B., Simpson, A. A., & Rossmann, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402992101 · Cited by 204 · cited 2×
“The protrusions surrounding the threefold axis create valley-like depressions between the two- and threefold axes, as observed in Aleutian mink disease virus and B19.”
MethodWeber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203
Lochrie, M. A., Tatsuno, G. P., Christie, B., McDonnell, J. W., Zhou, S., Surosky, R., Pierce, G. F., & Colosi, P. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.821-834.2006 · Cited by 201 · cited 14×
“mutagenesis of capsid surface residues followed by transduction experiments with human HepG2 cells (44).”
BackgroundInfluentialBleker, S., Sonntag, F., & Kleinschmidt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2528-2540.2005 · Cited by 200 · cited 2×
“In addition, the available cryo-EM and crystal structures of AAV2 have enabled the mapping of these functional properties onto the capsid (4, 35, 40, 44, 52, 70).”
BackgroundKronenberg, S., Böttcher, B., von der Lieth, C. W., Bleker, S., & Kleinschmidt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5296-5303.2005 · Cited by 198 · cited 1×
“The three-dimensional structure of AAV2 has been determined by X-ray crystallography (70) and cryo-electron microscopy (cryo-EM) with image reconstruction (39, 40), and the structures of AAV4 and AAV5 have been determined by cryo-EM (53, 62).”
MethodFarr, G. A., Zhang, L.-G., & Tattersall, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508477102 · Cited by 184
Reddy, V. S., Natarajan, P., Okerberg, B., Li, K., Damodaran, K. V., Morton, R. T., Brooks, C. L., & Johnson, J. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.11943-11947.2001 · Cited by 180 · cited 1×
“These R values are comparable to or better than those quoted for all available parvovirus capsid structures and those of viruses from other families, as detailed on the VIPER website at http://viperdb .scripps.edu ( 57 ).”
MethodRabinowitz, J. E., Bowles, D. E., Faust, S. M., Ledford, J. G., Cunningham, S. E., & Samulski, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4421-4432.2004 · Cited by 171 · cited 1×
““Pseudotyping” and “cross packaging” strategies (25, 27, 55, 56) that have enabled direct comparison of the capsids of representative serotypes of the distinct AAV clades, as well as mutagenesis studies on AAV2, the best-studied serotype, have shown that the capsid sequence determines tissue tropism, transduction effi…”
BackgroundScalable Purification of Adeno-Associated Virus Type 2, 4, or 5 Using Ion-Exchange Chromatography
Kaludov, N., Handelman, B., & Chiorini, J. A. (2002) · Human Gene Therapy · doi:10.1089/104303402320139014 · Cited by 167 · cited 1×
“However, the only antibody available for AAV4 was generated to a predicted surface peptide (residues 455 to 467 [AAV4 VP1 numbering]) (32).”
BackgroundSelf-citationFitzgerald, P. M. D. (1992) · Oxford University Press eBooks · doi:10.1093/oso/9780198553847.003.0025 · Cited by 166
Electron cryo‐microscopy and image reconstruction of adeno‐associated virus type 2 empty capsids
Kronenberg, S., Kleinschmidt, J. A., & Böttcher, B. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve234 · Cited by 161 · cited 3×
“In addition, the available cryo-EM and crystal structures of AAV2 have enabled the mapping of these functional properties onto the capsid (4, 35, 40, 44, 52, 70).”
BackgroundMethodGeneration and characterization of chimeric recombinant AAV vectors
Hauck, B., Chen, L., & Xiao, W. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00012-1 · Cited by 160 · cited 1×
““Pseudotyping” and “cross packaging” strategies (25, 27, 55, 56) that have enabled direct comparison of the capsids of representative serotypes of the distinct AAV clades, as well as mutagenesis studies on AAV2, the best-studied serotype, have shown that the capsid sequence determines tissue tropism, transduction effi…”
BackgroundWistuba, A., Weger, S., Kern, A., & Kleinschmidt, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5311-5319.1995 · Cited by 147 · cited 1×
“Peptide mapping has been used to identify both linear and conformationdependent epitopes on the AAV2 capsid (66, 67).”
BackgroundCanine Parvovirus Capsid Structure, Analyzed at 2.9 Å Resolution
Xie, Q., & Chapman, M. S. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0657 · Cited by 134 · cited 4×
“Interestingly, CPV and MVM also have similar distributions of acidic/basic residues on the walls of their twofold axes extending toward the threefold axis (data not shown).”
BackgroundInfluentialHanda, A., Muramatsu, S.-I., Qiu, J., Mizukami, H., & Brown, K. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-8-2077 · Cited by 131 · cited 1×
“with different binding affinities (24, 56).”
The Structure of Human Parvovirus B19 at 8 Å; Resolution
Agbandje, M., Kajigaya, S., McKENNA, R. V., Young, N. S., & Rossmann, M. G. (1994) · Virology · doi:10.1006/viro.1994.1460 · Cited by 116 · cited 2×
“The protrusions surrounding the threefold axis create valley-like depressions between the two- and threefold axes, as observed in Aleutian mink disease virus and B19.”
MethodSelf-citationStructure of Adeno-Associated Virus Serotype 5
Walters, R. W., Agbandje-McKenna, M., Bowman, V. D., Moninger, T. O., Olson, N. H., Seiler, M., Chiorini, J. A., Baker, T. S., & Zabner, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3361-3371.2004 · Cited by 114
Self-citationStructure of Adeno-Associated Virus Type 4
Padron, E., Bowman, V., Kaludov, N., Govindasamy, L., Levy, H., Nick, P., McKenna, R., Muzyczka, N., Chiorini, J. A., Baker, T. S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5047-5058.2005 · Cited by 108
Self-citationChipman, P. R., Agbandje-McKenna, M., Kajigaya, S., Brown, K. E., Young, N. S., Baker, T. S., & Rossmann, M. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7502 · Cited by 106 · cited 2×
“The protrusions surrounding the threefold axis create valley-like depressions between the two- and threefold axes, as observed in Aleutian mink disease virus and B19.”
MethodSelf-citationChen, S., Kapturczak, M., Loiler, S. A., Zolotukhin, S., Glushakova, O. Y., Madsen, K. M., Samulski, R. J., Hauswirth, W. W., Campbell-Thompson, M., Berns, K. I., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.235 · Cited by 102 · cited 1×
“Recent studies suggested that AAV1 utilizes sialic acid for transduction (10).”
BackgroundThe Canine Parvovirus Empty Capsid Structure
Wu, H., & Rossmann, M. G. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1502 · Cited by 101 · cited 1×
“A similar ranking of buried surface areas is observed for interface formation in autonomous parvovirus capsids (68, 71).”
BackgroundSecreted and Transmembrane Mucins Inhibit Gene Transfer with AAV4 More Efficiently than AAV5
Walters, R. W., Pilewski, J. M., Chiorini, J. A., & Zabner, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200292200 · Cited by 86 · cited 1×
“AAV4 binds to 2,3 O-linked sialic acids, while AAV5 requires 2-3 Nlinked sialic acids for cell attachment and entry (31, 63, 64).”
BackgroundSelf-citationFlotte, T. R., Agarwal, A., Wang, J., Song, S., Fenjves, E. S., Inverardi, L., Chesnut, K. A., Afione, S. A., Loiler, S., Wasserfall, C. H., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.3.515 · Cited by 86
Kontou, M., Govindasamy, L., Nam, H.-J., Bryant, N., Llamas-Saiz, A. L., Foces-Foces, C., Hernando, E., Rubio, M.-P., McKenna, R., Almendral, J. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.10931-10943.2005 · Cited by 85
Self-citationMcKenna, R., Olson, N. H., Chipman, P. R., Baker, T. S., Booth, T. F., Christensen, J., Aasted, B., Fox, J. M., Bloom, M. E., Wolfinbarger, J. B., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6882-6891.1999 · Cited by 84 · cited 1×
“Surprisingly, the AAV capsid surface topology is similar in architecture to those of the autonomous parvovirus Aleutian mink disease virus (47) and human parvovirus B19 virus (B19) (1, 12, 34), despite very low VP amino acid sequence identity (53).”
MethodSelf-citationLiu, G., Martins, I. H., Chiorini, J. A., & Davidson, B. L. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302554 · Cited by 84 · cited 1×
“tems of mice (13, 43) and for retinal pigmented epithelium in”
BackgroundSelf-citationLópez-Bueno, A., Rubio, M.-P., Bryant, N., McKenna, R., Agbandje-McKenna, M., & Almendral, J. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1563-1573.2006 · Cited by 79 · cited 1×
“Mutagenesis and structural studies of CPV and MVM, respectively, showed that residues on the walls of the twofold axes at the bases of their threefold protrusions which are structurally equivalent or close to the acidic/basic residues in the AAVs function as sialic acid binding regions (45, 61).”
BackgroundSelf-citationFarr, G. A., Cotmore, S. F., & Tattersall, P. (2006) · Journal of Virology · doi:10.1128/jvi.80.1.161-171.2006 · Cited by 71 · cited 1×
“The cylindrical channel at the fivefold axis of the parvovirus capsid, which is implicated in packaging of the parvovirus genome and the phospholipase activity of the VP1 unique region (4, 16, 17), is conserved.”
BackgroundMiller, E. B., Gurda-Whitaker, B., Govindasamy, L., McKenna, R., Zolotukhin, S., Muzyczka, N., & Agbandje-McKenna, M. (2006) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309106048184 · Cited by 58
Self-citationCorrelating structure with function in the viral capsid
Agbandje‐McKenna, M., & Chapman, M. S. (2005) · CRC Press eBooks · doi:10.1201/b13393-14 · Cited by 57
Self-citationTresnan, D. B., Southard, L., Weichert, W. S., Sgro, J.-Y., & Parrish, C. R. (1995) · Virology · doi:10.1006/viro.1995.1385 · Cited by 51 · cited 1×
“Mutagenesis and structural studies of CPV and MVM, respectively, showed that residues on the walls of the twofold axes at the bases of their threefold protrusions which are structurally equivalent or close to the acidic/basic residues in the AAVs function as sialic acid binding regions (45, 61).”
BackgroundAtomic structure of viral particles
Chapman, M. S., & Agbandje‐McKenna, M. (2005) · CRC Press eBooks · doi:10.1201/b13393-13 · Cited by 49
Self-citationKaludov, N. K., Padron, E., Govindasamy, L., McKENNA, R. V., Chiorini, J. A., & Agbandje‐McKenna, M. (2003) · Virology · doi:10.1016/s0042-6822(02)00037-5 · Cited by 32
Self-citation
Research works printed but not linked: 2
- Kleywegt, G. J., and T. A. Jones. 1994. Halloween…masks and bones, p. 59-66. In S. Bailey, R. Hubbard, and D. Waller (ed.), From first map to final model. SERC Daresbury Laboratory, Chilton, United Kingdom.
- Muzyczka, N., and K. I. Berns. 2001. Parvoviridae: the viruses and their replication, p. 2327-2360. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, New York, N.Y.
Cited by
The current landscape of nucleic acid therapeutics
Kulkarni, J. A., Witzigmann, D., Thomson, S. B., Chen, S., Leavitt, B. R., Cullis, P. R., & van der Meel, R. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00898-0 · Cited by 1,371
Engineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Asokan, A., Schaffer, D. V., & Jude Samulski, R. (2012) · Molecular Therapy · doi:10.1038/mt.2011.287 · Cited by 465
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
Bowles, D. E., McPhee, S. W., Li, C., Gray, S. J., Samulski, J. J., Camp, A. S., Li, J., Wang, B., Monahan, P. E., Rabinowitz, J. E., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.237 · Cited by 400
Self-citationTerminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
Shen, S., Bryant, K. D., Brown, S. M., Randell, S. H., & Asokan, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210922 · Cited by 282
Metadata
- Authors
- Govindasamy, L., Padron, E., McKenna, R., Muzyczka, N., Kaludov, N., Chiorini, J. A., & Agbandje-McKenna, M.
- Affiliations
- Department of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida 32610
- University of Florida (US)
- National Institutes of Health (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-12
- Volume
- 80
- Issue
- 23
- Pages
- 11556-11570
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC1642620
- OpenAlex
- W2149678280
- Cited by
- 205
- References
- 71
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 14 · 2023: 18 · 2022: 11 · 2021: 17 · 2020: 13 · 2019: 8 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 9 · 2014: 10 · 2013: 13 · 2012: 16
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01-HL51811, P01HL051811)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Infectious Diseases › Parvovirus B19 Infection Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- capsid protein, AAV2, heparin binding, receptor recognition, transduction, gene delivery vectors
- MeSH terms
- Dependovirus, Binding Sites, Capsid, Phenotype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.